[Leishmania epidemiology, diagnosis, chemotherapy and vaccination approaches in the international network of Pasteur Institutes]. / Les leishmanioses vues au travers du réseau international des Instituts Pasteur.
Med Sci (Paris)
; 29(12): 1151-60, 2013 Dec.
Article
in Fr
| MEDLINE
| ID: mdl-24356147
ABSTRACT
Protozoan parasites of the genus Leishmania generate severe human diseases termed leishmaniases. Due to their frequency and the severity of certain clinical forms, these diseases represent a major public health problem and limit the economic growth in various developing countries. The presence of Pasteur Institutes in countries with endemic leishmaniasis has provided important incentives to develop a strong public health agenda in the Pasteur scientific community with respect to this important disease. A concerted effort is now coordinated through the recently created LeishRIIP platform (www.leishriip.org), which aims to identify synergies and complementary expertise between the eleven members of the international network of Pasteur Institutes working on various aspects of the disease including epidemiology, diagnosis, chemotherapy and vaccination.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leishmaniasis
/
Vaccination
/
Leishmania
/
Antiprotozoal Agents
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limits:
Animals
/
Humans
Language:
Fr
Journal:
Med Sci (Paris)
Journal subject:
MEDICINA
Year:
2013
Document type:
Article
Affiliation country:
Túnez